Stocks & Investing
Thu, August 15, 2024
[ Thu, Aug 15th 2024
] - WOPRAI
Tue, July 30, 2024
[ Tue, Jul 30th 2024
] - WOPRAI
Tue, December 26, 2023
[ Tue, Dec 26th 2023
] - WOPRAI
Wed, October 25, 2023
[ Wed, Oct 25th 2023
] - WOPRAI
Fri, August 18, 2023
[ Fri, Aug 18th 2023
] - WOPRAI
Mon, December 13, 2021
[ Mon, Dec 13th 2021
] - WOPRAI
Fri, January 15, 2021
[ Fri, Jan 15th 2021
] - WOPRAI
Jason Zemansky Maintained (SNDX) at Strong Buy with Increased Target to $31 on, Aug 15th, 2024
Jason Zemansky of B of A Securities, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Increased Target from $30 to $31 on, Aug 15th, 2024.
Jason has made no other calls on SNDX in the last 4 months.
There are 4 other peers that have a rating on SNDX. Out of the 4 peers that are also analyzing SNDX, 0 agree with Jason's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Jason
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $33 on, Tuesday, August 6th, 2024
- Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $37 on, Friday, June 28th, 2024
- Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $42 on, Wednesday, June 26th, 2024
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $30 on, Thursday, May 9th, 2024
